cystetic Medicines
Champaign, US · Founded 2019 · Delaware corporation · 1 known investors
Cystetic Medicines develops molecular prosthetics to treat cystic fibrosis, specifically targeting the 10% of CF patients who cannot benefit from existing modulator therapies due to little-to-no CFTR protein. The therapy acts as a functional replacement for the missing CFTR protein to restore airway function.
BiotechHealthtechMedical Devices
Founders & leadership
PW
PETER W STEELMANDirector
JR
JONATHAN RAMOSDirector
PB
PETER B. FINNExecutive Officer
MB
MARTIN BURKE, MD., PH.D.Director
ZS
ZHENG SUDirector
DM
Dr. Martin D. BurkeCo-founder
DM
Dr. Michael J. WelshCo-founder
DJ
Dr. Jeffry WeersChief Technology Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5MraisedNov 2020 · 2 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- PETER W STEELMANDirector
- JONATHAN RAMOSDirector
- PETER B. FINNExecutive Officer
- MARTIN BURKE, MD., PH.D.Director
- ZHENG SUDirector
- Offering amount
- $25.1M
- Amount sold
- $5M
- Minimum investment
- $1
- Proceeds to insiders
- $1
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.